DH
$1.14+0.03 (+3.18%)
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers an...
Recent News
Definitive Healthcare (DH) Earnings Transcript
Kevin D. Coop: Thank you, Jonathan, and thanks to all of you for joining us this afternoon to review Definitive Healthcare Corp.'s fourth quarter 2025 financial results. On today's call, I will provide highlights from our fourth quarter performance, review the operational progress we have made in 2025, and outline our key strategic priorities for 2026. Let me begin by reviewing our financial results for the fourth quarter, which were at or above the high end of our guidance ranges on both the top and bottom line.
Definitive Healthcare Corp. Q4 2025 Earnings Call Summary
Moby summary of Definitive Healthcare Corp.'s Q4 2025 earnings call
Definitive Healthcare Corp (DH) Q4 2025 Earnings Call Highlights: Navigating Revenue Challenges ...
Despite a slight revenue decline, Definitive Healthcare Corp (DH) focuses on data differentiation and strategic partnerships to enhance customer retention and satisfaction.
Definitive Healthcare Q4 Earnings Call Highlights
Definitive Healthcare (NASDAQ:DH) reported fourth-quarter 2025 results that management said landed at or above the high end of its guidance ranges, while outlining continued work to improve retention and rebuild a path to sustainable revenue growth. Q4 results and full-year performance Total revenu
Definitive Healthcare Corp. (DH) Matches Q4 Earnings Estimates
Definitive Healthcare (DH) delivered earnings and revenue surprises of +2.92% and +3.27%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?